The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Riley Antony A since 2018.
This trader's CIK number is 1339375.
At the time of last reporting, Riley Antony A was the CHIEF FINANCIAL OFFICER of Forte Biosciences, Inc.. (stock ticker symbol FBRX).
Also see all insider trading activities at Forte Biosciences, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | KRYS | 0 | $0 | 0 | $0 | 6,250 | $61,562 |
2018 | KRYS | 2,800 | $30,100 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | FBRX | 0 | $0 | 0 | $0 | 750 | $0 |
2024 | FBRX | 22,514 | $124,997 | 0 | $0 | 28,500 | $0 |
2023 | FBRX | 0 | $0 | 0 | $0 | 28,125 | $0 |
2021 | FBRX | 0 | $0 | 25,000 | $106,375 | 0 | $0 |
2020 | FBRX | 6,700 | $96,445 | 0 | $0 | 0 | $0 |
1. Krystal Biotech, Inc. (KRYS)
2. Forte Biosciences, Inc. (FBRX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-11-19 | KRYS | Option Ex | 6,250 | 9.85 | 61,562 |
2018-05-22 | KRYS | Buy | 2,800 | 10.75 | 30,100 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-07-01 | FBRX | Option Ex | 375 | .00 | 0 |
2025-04-01 | FBRX | Option Ex | 375 | .00 | 0 |
2024-11-21 | FBRX | Buy | 22,514 | 5.55 | 124,997 |
2024-10-01 | FBRX | Option Ex | 375 | .00 | 0 |
2024-07-01 | FBRX | Option Ex | 9,375 | .00 | 0 |
2024-04-01 | FBRX | Option Ex | 9,375 | .00 | 0 |
2024-01-01 | FBRX | Option Ex | 9,375 | .00 | 0 |
2023-10-01 | FBRX | Option Ex | 9,375 | .00 | 0 |
2023-07-01 | FBRX | Option Ex | 9,375 | .00 | 0 |
2023-04-01 | FBRX | Option Ex | 9,375 | .00 | 0 |
2021-09-07 | FBRX | Sale | 25,000 | 4.25 | 106,375 |
2020-06-26 | FBRX | Buy | 4,700 | 14.52 | 68,225 |
2020-06-29 | FBRX | Buy | 2,000 | 14.11 | 28,220 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Riley Antony A (CHIEF FINANCIAL OFFICER of Forte Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.